58 - Progress in Immunotherapy for Breast Cancer

Immunotherapy has offered dramatic benefits to many cancer patients, with melanoma, lung cancer, bladder cancer, among others. Many advances in breast cancer therapy have also improved the outcome of breast cancer patients including immunotherapy for specific subtypes of breast cancer. This lecture will provide an overview of immunotherapy for breast cancer including Her-2/Neu targeted therapy, anti-PD-L1 therapy for triple negative breast cancer, anti-PD-1 therapy for metastatic breast cancer with DNA mismatch repair deficiency as well as challenges and future directions.